Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ascorbyl phosphate is a synthetic and stabilized derivative of vitamin C (ascorbic acid), commonly found in the forms of magnesium ascorbyl phosphate and sodium ascorbyl phosphate. It is primarily used in cosmetic and pharmaceutical preparations for its antioxidant properties and ability to promote collagen synthesis. As an active precursor to vitamin C, it is more stable than pure ascorbic acid and can be readily absorbed into the skin where it exerts hydrating effects, neutralizes free radicals (antioxidant action), stimulates collagen production for anti-aging benefits, and may inhibit melanin production to lighten skin tone. Its mechanism involves conversion into free ascorbic acid by enzymatic degradation in the skin[1][2][6]. The compound is approved for use in topical formulations at concentrations typically ranging from 0.001% to 3%[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ascorbyl phosphate.